Walgreens Boots Alliance, Inc. (WBA)

Market Cap	10.37B
Revenue (ttm)	154.58B +6.2%
Net Income	-6.30B
EPS	-7.29
Shares Out	865.56M
PE Ratio	n/a
Forward PE	7.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	452,081,061
Open	11.92
Previous Close	11.92
Day's Range	11.90 - 12.11
52-Week Range	8.08 - 13.25
Beta	0.77
Analysts	Hold
Price Target	10.59 (-11.6%)
Earnings Date	Oct 14, 2025

About WBA

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. The company operates in three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in the operation of retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offer health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers the sa...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1901
• Employees: 312,000
• Stock Exchange: NASDAQ
• Ticker Symbol: WBA

Financial Performance

In 2024, Walgreens Boots Alliance's revenue was $147.66 billion, an increase of 6.17% compared to the previous year's $139.08 billion. Losses were -$8.64 billion, 180.4% more than in 2023.

Analyst Summary

According to 11 analysts, the average rating for WBA stock is "Hold." The 12-month stock price target is $10.59, which is a decrease of -11.60% from the latest price.

Price Target

$10.59

(-11.60% downside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Aug 30, 2025

Data Sources Report a data error